Improving the measurement of everyday functional outcomes in diverse populations of older adults with Alzheimer's disease and related disorders
改善患有阿尔茨海默病和相关疾病的不同老年人群的日常功能结果的测量
基本信息
- 批准号:9371281
- 负责人:
- 金额:$ 7.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-15 至 2019-04-30
- 项目状态:已结题
- 来源:
- 关键词:Activities of Daily LivingAddressAffectAfrican AmericanAlzheimer disease detectionAlzheimer&aposs DiseaseAlzheimer&aposs disease riskAreaAssessment toolCaliforniaCaucasiansClinicalCognitionCognitiveComorbidityComprehensionDataDementiaDevelopmentDiagnosisDiseaseDisease ProgressionEarly DiagnosisEducationElderlyEthnic OriginEthnic groupFamiliarityFederal GovernmentFoundationsFundingHealthHealth behaviorImpaired cognitionInterviewLatinoLeadLife StyleLongitudinal cohortMeasurementMeasuresMedicalMethodsMinority GroupsModificationMonitorOutcomeOutcome MeasurePatient CarePopulationPopulation HeterogeneityPropertyPsychometricsQuestionnairesRaceReadingResearchRiskSubgroupSupportive careSymptomsTimeUnited StatesUniversitiesWorkaging populationanalytical methodbaseclinical carecohortdisabilityethnic diversityfunctional declinefunctional outcomeshealth care availabilityhealth differencehealth disparityhigh riskimprovedinformantinstrumentmembermild cognitive impairmentnovelpreventpublic health prioritiesracial and ethnicracial diversityracial minoritysoundtooltreatment response
项目摘要
Project Summary
The aging population in the United States is becoming more racially and ethnically diverse than ever before.
Health disparities have been well documented across diverse older adult populations, including evidence to
suggest that there may be increased rates of Alzheimer's disease (AD) and related disorders among some
groups. Researched aimed at understanding, preventing and ameliorating health disparities in AD is a major
public health priority. However, to study and address these health disparities requires psychometrically sound
and culturally appropriate assessment tools to sensitively measure early clinical signs associated with AD and
to provide good outcome measures to track disease progression and response to treatment. The measurement
properties of such assessment tools must be conceptually and psychometrically equivalent across diverse
populations. With previous NIA funding (Farias, AG 0215111, AG 031252) we developed a novel
questionnaire-based assessment tool (the Everyday Cognition scales (ECog) to measure very early limitations
in everyday functions. Our work has shown that subtle changes in everyday functions, as measured by the
ECog, can be used to identify older adults at increased risk for developing Mild Cognitive Impairment (MCI)
and dementia. However, our most recent work has shown that the current version of the ECog is less sensitive
to predicting disease progression in ethnic/racial minority subgroups (Latinos and African Americans) than it is
in non-Latino Caucasians. Such findings provide clear rationale for the need to adapt and further refine this
instrument to improve its utility as an early indicator of disease and as an outcome measure among diverse
populations. The proposed study will utilize a multi-method (quantitative and qualitative) approach to evaluate
and improve the measurement equivalence of the ECog among diverse older adult populations. The aims of
this study are twofold. In Aim 1 we will utilize existing data from the University of California, Davis Alzheimer
Disease Center's multiethnic longitudinal cohort to quantitatively evaluate which items of the ECog display
evidence of poor measurement equivalence across three racial/ethnic groups (African Americans, Latinos, and
non-Latino Caucasians) using sophisticated analytic methods. Informed by results of Aim 1, Aim 2 will employ
well-established cognitive interviewing methods to further evaluate and identify the reasons why particular
ECog items are problematic for specific racial/ethnic groups. For example, some items may not be readily
understood as intended and/or some items may not be appropriate the cultural context and lifestyle of some
groups. These items will be modified accordingly and a second wave of cognitive interviews will further
evaluate item revisions. Completion of this study will provide the critical formative work to improve our ability to
measure early changes in everyday function with comparable accuracy and precision across diverse older
adult populations.
项目摘要
美国的老龄化人口在种族和种族上比以往任何时候都变得更加多样化。
在不同的老年人群体中,健康差异已得到充分记录,包括证据
表明某些阿尔茨海默氏病(AD)和相关疾病的发生率可能会增加
组。旨在理解,预防和改善广告中健康差异的研究是主要的
公共卫生优先。但是,要研究和解决这些健康差异需要心理上的声音
以及具有文化适当的评估工具,以敏感地测量与AD和AD相关的早期临床标志
提供良好的结果措施以追踪疾病进展和对治疗的反应。测量
此类评估工具的属性必须在概念和心理上是等于不同的
人群。在以前的NIA资金(Farias,AG 0215111,AG 031252)中,我们开发了一个小说
基于问卷调查的评估工具(日常认知量表(ECOG),以衡量非常早期的限制
在日常功能中。我们的工作表明,日常功能的细微变化,由
ECOG可用于识别患有更为轻度认知障碍风险增加的老年人(MCI)
和痴呆症。但是,我们最近的工作表明,当前版本的ECOG敏感不太敏感
预测种族/种族少数族裔亚组(拉丁裔和非裔美国人)的疾病进展
在非拉丁裔高加索人中。这样的发现为需要适应和进一步完善这一点提供了明确的理由
改善其效用作为疾病早期指标的工具,并作为多样的结果措施
人群。拟议的研究将利用多方法(定量和定性)方法评估
并提高不同成年人种群中ECOG的测量等效性。目的
这项研究是双重的。在AIM 1中,我们将利用加利福尼亚大学戴维斯阿尔茨海默氏症的现有数据
疾病中心的多民族纵向队列,用于定量评估ECOG显示的哪些项目
三个种族/族裔群体(非裔美国人,拉丁裔和拉丁裔和
非拉丁裔高加索人)使用复杂的分析方法。通过AIM 1的结果告知,AIM 2将采用
建立了良好的认知访谈方法,以进一步评估和确定为什么特定的原因
ECOG项目对于特定的种族/族裔群体是有问题的。例如,某些项目可能不容易
理解为预期和/或某些项目可能不适合某些文化背景和生活方式
组。这些项目将进行相应修改,第二波认知访谈将进一步
评估项目修订。这项研究的完成将提供重要的形成性工作,以提高我们的能力
衡量日常功能的早期变化,以相当的精度和精度
成人人群。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SARAH E TOMASZEWSKI-FARIAS其他文献
SARAH E TOMASZEWSKI-FARIAS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SARAH E TOMASZEWSKI-FARIAS', 18)}}的其他基金
Understanding the Pathway to Functional Disability in Alzheimer's disease
了解阿尔茨海默病导致功能障碍的途径
- 批准号:
8123623 - 财政年份:2008
- 资助金额:
$ 7.85万 - 项目类别:
Understanding the Pathway to Functional Disability in Alzheimer's disease
了解阿尔茨海默病导致功能障碍的途径
- 批准号:
8121382 - 财政年份:2008
- 资助金额:
$ 7.85万 - 项目类别:
Understanding the Pathway to Functional Disability in Alzheimer's disease
了解阿尔茨海默病导致功能障碍的途径
- 批准号:
7674742 - 财政年份:2008
- 资助金额:
$ 7.85万 - 项目类别:
Understanding the Pathway to Functional Disability in Alzheimer's disease
了解阿尔茨海默病导致功能障碍的途径
- 批准号:
7524369 - 财政年份:2008
- 资助金额:
$ 7.85万 - 项目类别:
Understanding the Pathway to Functional Disability in Alzheimer's disease
了解阿尔茨海默病导致功能障碍的途径
- 批准号:
7907594 - 财政年份:2008
- 资助金额:
$ 7.85万 - 项目类别:
Understanding the Pathway to Functional Disability in Alzheimer's disease
了解阿尔茨海默病导致功能障碍的途径
- 批准号:
8314006 - 财政年份:2008
- 资助金额:
$ 7.85万 - 项目类别:
Understanding the Pathway to Functional Disability in Alzheimer's disease
了解阿尔茨海默病导致功能障碍的途径
- 批准号:
8532498 - 财政年份:2008
- 资助金额:
$ 7.85万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Pterygopalatine Fossa (PPF) Block as an Opioid Sparing Treatment for AcuteHeadache in Aneurysmal Subarachnold Hemorrhage
翼腭窝 (PPF) 阻滞作为阿片类药物节省治疗动脉瘤性蛛网膜下腔出血的急性头痛
- 批准号:
10584712 - 财政年份:2023
- 资助金额:
$ 7.85万 - 项目类别:
Characterizing Vision Impairment and Its Impact on Independence in Older Adults
老年人视力障碍的特征及其对独立性的影响
- 批准号:
10590321 - 财政年份:2023
- 资助金额:
$ 7.85万 - 项目类别:
Cognitive Health and Modifiable Factors of Daily Sleep and Activities Among Dementia Family Caregivers
痴呆症家庭护理人员的认知健康状况以及日常睡眠和活动的可改变因素
- 批准号:
10643624 - 财政年份:2023
- 资助金额:
$ 7.85万 - 项目类别:
A First-in-class Topical Immunoregulatory Therapeutic for Psoriasis
一流的牛皮癣局部免疫调节疗法
- 批准号:
10820331 - 财政年份:2023
- 资助金额:
$ 7.85万 - 项目类别: